Key Details of Meetings
The company has scheduled a series of one-on-one meetings with specific investors and analysts. All meetings are scheduled to be held in-person in Mumbai on September 9, 2026.
The detailed schedule is as follows:
- Date: September 9, 2026 | Entity: Breakout Capital | Mode: In-person | Place: Mumbai | Type: One on One
- Date: September 9, 2026 | Entity: UTI | Mode: In-person | Place: Mumbai | Type: One on One
- Date: September 9, 2026 | Entity: Kotak Mutual Fund | Mode: In-person | Place: Mumbai | Type: One on One
- Date: September 9, 2026 | Entity: Param Capital | Mode: In-person | Place: Mumbai | Type: One on One
Contingency Notice
The disclosure includes a note that the provided schedule and mode of meeting are subject to change due to exigencies on the part of the investor, analyst, or the company itself.
Company and Officer Details
The disclosure is signed by Rudalf Joseph Corriea, who holds the designation of Company Secretary & Compliance Officer for Alivus Life Sciences Limited. The company's Corporate Office is located at Technopolis Knowledge Park, A wing, Office No. 401 to 407, 4th Floor, Mahakali Caves Road, Andheri (E), Mumbai – 400093. Its Registered Office is at Plot No 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213, India. The company's Corporate Identification Number (CIN) is L74900PN2011PLC139963.